|Articles|March 24, 2020

World TB Day Promotes Awareness of World's Most Deadly Infectious Disease

World Tuberculosis Day is commemorated annually on March 24 to heighten awareness of the world’s most deadly infectious disease.

World Tuberculosis (TB) Day is commemorated annually on March 24th to raise awareness of the world’s most deadly infectious disease. In 2018, 10 million people fell ill with TB and 1.5 million died.

The World Health Organization (WHO) announced that the theme for this year’s TB Day is “It’s Time”.

“…the spotlight this year is on urgently accelerating the TB response to save lives and end suffering, building on high level commitments by Heads of State at the 2018 UN High-Level Meeting on TB,” according to the WHO statement.

March 24th is the anniversary of the day in 1882 that Robert Koch, MD, announced the discovery of Mycobacterium tuberculosis, which causes TB. It had previously been believed by many that TB was inherited rather than being an infectious disease.

The “It’s Time” theme highlights that now is the time to scale up access to prevention and treatment, to ensure sustainable resources are dedicated to TB research, and to ramp up an equitable global strategy to control an infectious disease that is responsible for immense social burdens.

The WHO listed TB among its urgent infectious disease challenges to address this decade, noting that TB, HIV, viral hepatitis, and malaria will lead to an estimated 4 million deaths in 2020.

“CDC [US Centers for Disease Control and Prevention] joins the global community to recognize World Tuberculosis (TB) Day—an important moment to unite in renewed commitment to ending TB, an airborne disease that knows no borders,” according to the CDC statement.

An article in the CDC’s Morbidity and Mortality Weekly Report presented a range of information on TB, from both the US and global health figures.

“In 2019, a provisional total of 8,920 TB cases were reported in the United States (incidence = 2.7 cases per 100,000 persons), a 1.1% decrease from the 9021 cases reported during 2018 and the lowest number of U.S. cases recorded since reporting began in 1953,” the authors wrote.

The report also detailed that the 10 million cases and 1.5 million deaths from TB worldwide in 2018 represent 2% and 5% declines from 2017, respectively.

In addition, about 862,000 reported TB infections occurred in people living with HIV. In 2018, 1.8 million people living with HIV began TB preventative treatment, which is an 88% increase from 2017.

Past research has shown that in TB-endemic areas, community-wide screening regardless of symptoms may be helpful.


Related to this article

Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
FAQ: Shamonda Virus
As France confirms the first documented human Shamonda virus infection, a fatal encephalitis in a stem cell transplant recipient, this FAQ explains what the virus is, where it has spread, how the case was diagnosed, how the patient was likely infected and what clinicians should watch for.
ID Week Highlights Part 1
In this first IDWeek 2026 roundup, oral olorofim matched AmBisome in invasive aspergillosis, aztreonam-avibactam held activity as MBL-producing CRE rose, pritelivir cut hospitalizations in refractory HSV, and zelicapavir shortened RSV symptoms in high-risk adults.